Sign In
Buy IRTC
$104.56
-0.94 (-0.89%)
At Close: Jun 03, 2026
SAN FRANCISCO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) announced results from the Oxford University-led A ctive M onitoring for A tria L FI brillation (AMALFI) rando
iRhythm Technologies to Participate in Upcoming Investor Conferences
04:30pm, Wednesday, 20'th Aug 2025
SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict
Investor Short Report Flags Steep Downside Risk For iRhythm Technologies
12:53pm, Monday, 18'th Aug 2025
Spruce Point Capital Management issued a detailed report on iRhythm Technologies, Inc. IRTC on Monday, projecting a long-term downside risk of 40% to 70% for its stock.
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority
08:05am, Monday, 18'th Aug 2025
SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc . (NASDAQ:IRTC) announced the publication of the real-world evidence study: Assessment of Variation in AmbuLatory Cardiac MON
iRhythm (IRTC) Q2 Revenue Jumps 26%
11:49am, Friday, 01'st Aug 2025
iRhythm Technologies (IRTC 17.81%), a medical device company specializing in cardiac monitoring technology, reported its Q2 FY2025 results on July 31, 2025. The highlight was record revenue (GAAP) of
iRhythm Technologies, Inc. (IRTC) Q2 2025 Earnings Call Transcript
09:49pm, Thursday, 31'st Jul 2025
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Daniel G. Wilson - CFO & Principal Financial Officer Quentin S.
iRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates
06:41pm, Thursday, 31'st Jul 2025
iRhythm Technologies (IRTC) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to a loss of $0.61 per share a year ago.
iRhythm Technologies Announces Second Quarter 2025 Financial Results
04:05pm, Thursday, 31'st Jul 2025
SAN FRANCISCO, July 31, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preve
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues
Will iRhythm Technologies (IRTC) Report Negative Earnings Next Week? What You Should Know
11:07am, Thursday, 24'th Jul 2025
iRhythm Technologies (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025
04:30pm, Thursday, 17'th Jul 2025
SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict
NEW YORK and NEW ORLEANS , July 11, 2025 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
iRhythm Technologies Announces Board Member Retirements and New Director Appointments
08:30am, Monday, 07'th Jul 2025
SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and preven
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues
New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease
